Physician profile
Paul Duong
NPI 1700912920
$11,312.15
in general payments reported to CMS, 2019-2025
30 companies · $977 in 2025
The $977 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,173 · 2020: $1,710 · 2021: $932 · 2022: $1,692 · 2023: $2,761 · 2024: $2,067 · 2025: $977.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,805.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,667.53 | 2021-2025 | Micra, Resolute Onyx, Azure Xt Dr Mri Surescan |
| Edwards Lifesciences Corporation | $1,805.25 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $1,666.20 | 2019-2025 | Cardiomems, Gallant, Jot Dx |
| Medtronic Vascular, INC. | $861.77 | 2019-2020 | |
| Abiomed | $790.62 | 2021-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $606.65 | 2019-2025 | |
| Boston Scientific Corporation | $599.05 | 2020-2023 | Angiojet Ultra 5000a, Avvigo Guidance System |
| Inari Medical, INC. | $435.40 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $269.54 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals Lp | $248.07 | 2019-2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $223.36 | 2021-2023 | Xarelto |
| Biosense Webster, INC. | $209.03 | 2023-2024 | Carto 3, Soundstar |
| Pfizer INC. | $145.04 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $128.31 | 2019-2023 | Jardiance |
| Novo Nordisk INC | $125.06 | 2023-2025 | Wegovy, Ozempic |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $101.77 | 2021-2025 | Repatha, Repatha |
| Kestra Medical Technology Services, INC. | $73.94 | 2022-2025 | Assure Wcd |
| Chiesi USA, INC. | $71.00 | 2019-2022 | |
| Atricure, INC. | $65.08 | 2024 | |
| Cardiovascular Systems INC. | $52.60 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $24.07 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $20.34 | 2023 | Opsumit, Uptravi |
| Philips North America LLC | $18.14 | 2023 | |
| Angiodynamics, INC. | $17.69 | 2024 | Auryon Laser System 100-120 Vac |
| Impulse Dynamics (USA) INC. | $17.02 | 2023 | Optimizer |
| Kiniksa Pharmaceuticals, Ltd. | $15.87 | 2023 | Arcalyst |
| Inspire Medical Systems, INC. | $15.32 | 2025 | Inspire |
| Lilly USA, LLC | $14.24 | 2025 | Zepbound, Mounjaro |
| Sanofi-Aventis U.S. LLC | $12.42 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Duong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.